SCHEMBL252667

SCHEMBL252667

CCCCCCCCCCCCCCCCN[C@@H](CS)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 2/20 0.49
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.46
ALOX15 P16050 1/20 0.46
NFKB1 P19838 1/20 0.46
PTGS2 P35354 1/20 0.46
THPO P40225 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
EPHX1 P07099 6/20 0.44
ACE P12821 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
GPR84 Q9NQS5 3/20 0.41
FFAR1 O14842 1/20 0.41
PLA2G2A P14555 2/20 0.41
PLA2G5 P39877 2/20 0.41
CASP2 P42575 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7201072 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL931570 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL252666 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL931571 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL8612865 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL25211227 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL21243388 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL21291888 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL20553468 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB
SCHEMBL5801833 1.00 NOD1 (0.49) NOD1MAPTSMN1; SMN2KDM4ETHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250009663-A1 Mouthwash For Oral Care Benefits FERTIN PHARMA A/S (DK) 2025-01-09 US claimed
CN-118460470-A Malignant pleural effusion organoid culture method 南京医科大学 2024-08-09 CN claimed
CN-116656613-A Thymus cancer organoid culture solution, culture method and application 福州大学 2023-08-29 CN claimed
US-20250262274-A1 Designed Biosensors for Enhanced T Cell Therapy ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 2025-08-21 US disclosed
WO-2024256627-A1 NOVEL INNATE LYMPHOID CELLS (ILCS) KING'S COLLEGE LONDON (GB) 2024-12-19 WO disclosed
CN-118460470-A Malignant pleural effusion organoid culture method 南京医科大学 2024-08-09 CN disclosed
EP-4367220-A1 METHODS OF GENERATING MESENCHYAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS IN A BIOREACTOR SYSTEM Brainstorm Cell Therapeutics Ltd. (IL) 2024-05-15 EP disclosed
CN-117025537-A Special culture solution for small cell lung cancer organoids and application thereof 福州大学 2023-11-10 CN disclosed
CN-116656613-A Thymus cancer organoid culture solution, culture method and application 福州大学 2023-08-29 CN disclosed
CN-116656613-A Thymus cancer organoid culture solution, culture method and application 福州大学 2023-08-29 CN disclosed
WO-2023281502-A1 METHODS OF GENERATING MESENCHYAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS IN A BIOREACTOR SYSTEM BRAINSTORM CELL THERAPEUTICS LTD. (IL) 2023-01-12 WO disclosed
WO-2001015709-A1 USE OF rAFP TO INHIBIT OR PREVENT APOPTOSIS ATLANTIC BIOPHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed
US-6133437-A ANTISENSE NUCLEIC ACID WHICH IS COMPLEMENTARY TO SPECIFIC HUMAN AND MOUSE NUCLEOTIDE SEQUENCES AND SUPPRESSES THE BIOLOGICAL ACTIVITY OF INHIBITOR OF APOPTOSIS IN VITRO; ANTICARCINOGENIC AGENTS APOPTOGEN, INC. (CA) 2000-10-17 US disclosed
US-6107088-A NUCLEIC ACID ENCODING A MAMMALIAN POLYPEPTIDE HAVING AT LEAST 50% SEQUENCE IDENTITY TO DEFINED AMINO ACID SEQUENCES AND INTERACT WITH INHIBITORS OF APOPTOSIS PROTEINS; FOR DIAGNOSIS AND THERAPY OF RELATED DISEASES; ANTIISCHEMIC AGENTS APOPTOGEN INC. (CA) 2000-08-22 US disclosed
WO-2000034236-A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2000-06-15 WO disclosed
EP-0892048-A2 XAF genes and polypeptides and their use for modulating apoptosis UNIVERSITY OF OTTAWA (CA) 1999-01-20 EP disclosed
EP-0837939-A2 MAMMALIAN APOPTOSIS INHIBITOR PROTEIN GENE FAMILY, PRIMERS, PROBES AND DETECTION METHODS UNIVERSITY OF OTTAWA (CA) 1998-04-29 EP disclosed
US-5632982-A Cytotoxic enhancement of TNF with copper THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 1997-05-27 US disclosed
WO-1997006255-A2 MAMMALIAN APOPTOSIS INHIBITOR PROTEIN GENE FAMILY, PRIMERS, PROBES AND DETECTION METHODS UNIVERSITY OF OTTAWA (CA) 1997-02-20 WO disclosed
US-5043328-A Gastrointestinal disorders HOECHST AKTIENGESELLSCHAFT (DE) 1991-08-27 US disclosed